Skip to content

Clinical trials

Phase 2/3 Emphysema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emphysema Phase: Phase 2/3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20092
20101
20111
20121
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aeris Therapeutics2
United Therapeutics2
Boston Scientific Corporation1
Broncus Technologies1
Heidelberg University1
Kamada, Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emphysema8
Pulmonary Disease, Chronic Obstructive4
Pulmonary Emphysema3
Hypertension, Pulmonary2
Lung Diseases2
Lung Diseases, Interstitial2
Pathologic Processes2
Respiratory Aspiration2
Respiratory Tract Diseases2
alpha 1-Antitrypsin Deficiency1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.